Connect with us
Prague Gaming & TECH Summit 2025 (25-26 March)

Fintech PR

USD 700 Billion Growth in Nutraceuticals Market Size 2023 – Industry Analysis, Market Trends, Market Growth, Opportunities | Sector Growing at 9.4% CAGR during the Forecast Period 2023 to 2030

Published

on

usd-700-billion-growth-in-nutraceuticals-market-size-2023-–-industry-analysis,-market-trends,-market-growth,-opportunities-|-sector-growing-at-9.4%-cagr-during-the-forecast-period-2023-to-2030

NEW YORK, July 10, 2023 /PRNewswire/ — The global nutraceuticals market size was valued at USD 353 billion in 2022 and is expected to surpass USD 700 billion by 2030, registering a CAGR of 9.4% during the forecast period (2023- 2030), as highlighted in a report published by Facts and Factors.

Report Link with All Related Graphs & Charts: https://www.fnfresearch.com/nutraceuticals-market

Nutraceuticals Market: Overview

Nutraceuticals is a term used to describe a product that is derived from food sources and has additional health benefits in addition to providing food’s essential nutritional value. Food supplements, herbal products, and processed foods such as stews, cereals, and beverages are kept separate. These items are also used as medication and provide protection against chronic diseases.

According to the NCBI, nutraceuticals are used to improve health, slow the ageing process, prevent chronic diseases, and increase life expectancy. According to NIH researchers, nutraceuticals have attracted significant interest in the healthcare industry due to their therapeutic benefits. According to reports, nutraceuticals have been found to be effective against Alzheimer’s, cancer, allergies, diabetes, and Parkinson’s disease.

Get a Free Sample PDF of this Research Report for More Insights with Table of Content, Research Methodology, and Graphs – https://www.fnfresearch.com/sample/nutraceuticals-market

Our Free Sample Report Consists of the Following:

  • 2023 Updated Report Introduction, Overview, and In-depth industry analysis
  • 229+ Pages Research Report (Inclusion of Updated Research)
  • Provide Chapter-wise guidance on Request
  • 2023 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
  • Includes an Updated List of tables & figures
  • Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis
  • Facts and Factors Methodology

Key Industry Insights & Findings of the Nutraceuticals Market Reports:

  • As per the analysis, the nutraceuticals market share is likely to grow above a CAGR of around 9.4% between 2023 and 2030.
  • The nutraceuticals market size was worth around USD 353 billion in 2022 and is estimated to hit approximately USD 700 billion by 2030. Due to a variety of driving factors, the market is predicted to rise at a significant rate.
  • The global nutraceuticals market is anticipated to record massive growth over the forecast period owing to the humungous consumption of functional foods has translated into a rise in the demand for nutraceuticals.
  • Based on the product, the functional foods segment is predicted to contribute majorly towards the global market share over the forecast timeline.
  • In terms of ingredients, the probiotics segment is projected to record the highest CAGR over 2023-2030.
  • On the basis of application, the weight management & safety segment is slated to dominate the segmental surge over the forecast period.
  • Region-wise, the Asia-Pacific Nutraceuticals market is projected to register the highest CAGR during the assessment period.

Browse Complete Report Here | Nutraceuticals Market Size, Share, Growth Analysis Report By Product (Dietary Supplements, Functional Beverages, and Functional Foods), By Ingredient (Probiotics, Prebiotics, Sweeteners, Vitamins, Whey Proteins, Proteins, Omega-3, Minerals, Marine Ingredients, Lipids & Fatty Acids, Krill, Juices & Concentrates, Isoflavones, Glucosamine, Fruit & Vegetables, Flavors, Fibers, Fats & Oils, Fat Replacers, Essential Oils, Enzymes, Dairy Ingredients, Colostrum, Aloe Vera, Amino Acids, Carotenoids, Carnitine, and Carbohydrates), By Application (Weight Management & Safety, Bone & Joint Health, Energy & Endurance, Heart Health, Digestive Health, Animal Nutrition, Immune System, Women’s Health, and Post-Pregnancy & Reproductive Health), and By Region – Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2023 – 2030

Industry Growth Drivers:

  • Lifestyle-related disease awareness will drive worldwide market trends

Massive consumption of functional foods has resulted in an increase in demand for nutraceuticals, thereby accelerating the global expansion of the nutraceuticals market. The expansion of the global market will be driven by an increase in consumer concentration on health-promoting foods and awareness of lifestyle-related disorders.

In addition, a rise in consumer spending in developed nations and heightened health consciousness will expand the global market’s growth potential. Massive consumption of dietary supplements has shifted consumer preferences towards self-medication and treatment of lifestyle-related maladies, such as malnutrition. In turn, this has provided a solid foundation for global market expansion.

The expansion of the global nutraceuticals market has been greatly influenced by the ageing population, rising healthcare costs, and shifting dietary preferences. Global market demand has been positively impacted by technological advancements in the nutraceuticals industry and the use of artificial intelligence in the field.

Advertisement

Restraints:

  • The global expansion of the nutraceutical industry will be hampered by the escalating cost of ingredients

The expansion of the global nutraceuticals industry will be stymied by the challenges encountered by industry participants during the manufacturing process and the lengthy extraction of ingredients required to produce nutraceuticals. In addition, rising costs of nutraceutical constituents can impede the global expansion of the industry.

Directly Purchase a Copy of The Report with TOC | Quick Delivery Available @ https://www.fnfresearch.com/buynow/su/nutraceuticals-market

Global Nutraceuticals Market: Segmentation

The global market for nutraceuticals is segmented by product, ingredient, application, and region.   

The global nutraceuticals market is segmented by product into dietary supplements, functional beverages, and functional foods. In addition, it is anticipated that the functional foods segment, which accounted for over 40% of the global market share in 2022, will maintain its segmental dominance over the forecast period.

Ingredient-wise, the nutraceuticals industry across the globe is divided into probiotics, prebiotics, sweeteners, vitamins, whey proteins, proteins, omega-3, minerals, marine ingredients, lipids & fatty acids, krill, juices & concentrates, isoflavones, glucosamine, fruit & vegetables, flavours, fibres, fats & oils, fat replacers, essential oils, enzymes, dairy ingredients, colostrum, aloe vera, amino acids, carotenoids, carnitine and carbohydrates segments.

The global nutraceuticals market is segmented by application into weight management & safety, bone & joint health, energy & endurance, heart health, digestive health, animal nutrition, immune system, women’s health, and post-pregnancy & reproductive health.

Recent Developments:

  • In the second quarter of 2022, The Kellogg Company, a U.S.-based food manufacturing firm, launched a new protein snack bar comprising 6 gms of protein and 90 calories. For the record, the snack bar is provided in two delectable flavors, rich chocolaty brownie sundae, and sweet berry vanilla. The move is predicted to boost the growth of the global nutraceuticals industry.
  • In the first half of 2022, PepsiCo, Inc., a U.S.-based food company, introduced a hemp-infused drink in the U.S. Moreover, the energy drink branded as “Rockstar Unplugged”, comprises hemp seed oil, lemon balm, vitamin B, and spearmint. The strategic move will embellish the market growth trends in the U.S.

Have Any Query? Ask Our Experts: https://www.fnfresearch.com/inquiry/nutraceuticals-market

Competitive Players

The report contains qualitative and quantitative research on the global nutraceuticals market, as well as detailed insights and development strategies employed by the leading competitors. The report also provides an in-depth analysis of the market’s main competitors, as well as information on their competitiveness.

Advertisement

Some of the main players in the global nutraceuticals market include;

  • DSM
  • PepsiCo Inc.
  • Amway
  • Herbalife Nutrition Limited
  • Pfizer Inc.
  • Archer Daniels Midland Company
  • Nestle S.A.
  • The Kraft Heinz Company
  • General Mills
  • The Hain Celestial Group Inc.
  • BASF SE
  • Nature’s Bounty
  • Abbot Industries
  • General Mills Inc.
  • Danone Corporation
  • Glanbia Plc
  • Tyson Foods

Key questions answered in this report:

  • What is the growth rate forecast and market size for Nutraceuticals Market?
  • What are the key driving factors propelling the Nutraceuticals Market forward?
  • What are the most important companies in the Nutraceuticals Market Industry?
  • What segments does the Nutraceuticals Market cover?
  • How can I receive a free copy of the Nutraceuticals Market sample report and company profiles?

Report Scope:

Report Attribute

Report Details

Market Size in 2022

USD 353 Billion

Market Forecast in 2030

USD 700 Billion

Growth Rate

CAGR of 9.4%

Base Year

Advertisement

2022

Forecast Years

2023- 2030

Key Companies Covered

DSM, PepsiCo Inc., Amway, Herbalife Nutrition Limited, Pfizer Inc., Archer Daniels Midland Company, Nestle S.A., The Kraft Heinz Company, General Mills, The Hain Celestial Group Inc., BASF SE, Nature’s Bounty, Abbot Industries, General Mills Inc., Danone Corporation, Glanbia Plc, Tyson Foods., and others.

Segments Covered

By Product, Ingredient, Application, and Region

Regions Covered

North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa

Customization Scope

Advertisement

Avail customized purchase options to meet your exact research needs.

 

Request for Customization on this Report as per your requirements – https://www.fnfresearch.com/customization/nutraceuticals-market

(We tailor your report to meet your specific research requirements. Inquire with our sales team about customising your report.)

Regional Analysis:

  • North American nutraceuticals market will lead globally

North America, which accounted for more than 30 percent of the global nutraceuticals market’s revenue in 2022, is anticipated to experience profitable expansion during the forecast period. The expansion of the regional market over 2023-2030 may be influenced by a rise in consumer health concerns and rising awareness of nutraceuticals.

The increase in the geriatric population and consumer expenditure on healthcare products, as well as changes in lifestyles, will contribute to the expansion of regional market trends. A rise in healthcare spending in the United States will drive the expansion of the regional market.

In addition, the Asia-Pacific region is anticipated to register the highest CAGR in the anticipated timeframe for the nutraceuticals industry. A rise in living standards, a rise in per capita income, and an increase in population are factors that are likely to influence the growth of the regional industry.

Global Nutraceuticals Market is segmented as follows:

By Product Segment Analysis

  • Dietary Supplements
  • Functional Beverages
  • Functional Foods

By Ingredient Segment Analysis

  • Probiotics
  • Prebiotics
  • Sweeteners
  • Vitamins
  • Whey Proteins
  • Proteins
  • Omega-3
  • Minerals
  • Marine Ingredients
  • Lipids & Fatty Acids
  • Krill
  • Juices & Concentrates
  • Isoflavones
  • Glucosamine
  • Fruit & Vegetables
  • Flavors
  • Fibers
  • Fats & Oils
  • Fat Replacers
  • Essential Oils
  • Enzymes
  • Dairy Ingredients
  • Colostrum
  • Aloe Vera
  • Amino Acids
  • Carotenoids
  • Carnitine
  • Carbohydrates

By Application Segment Analysis

  • Weight Management & Safety
  • Bone & Joint Health
  • Energy & Endurance
  • Heart Health
  • Digestive Health
  • Animal Nutrition
  • Immune System
  • Women’s Health
  • Post-Pregnancy & Reproductive Health

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
    • Rest of Southeast Asia
  • The Middle East & Africa
    • GCC
    • South Africa
    • Rest of the Middle East & Africa
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America

 

Browse Other Related Research Reports from Facts & Factors

Advertisement

Browse Through Facts and Factors Coverage of the Global Food & Beverages Industry

Follow Us on – LinkedIn | Twitter | Facebook

About Us:

Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.

Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Contact Us:

Facts and Factors
Tel: +1 347 690-0211
USA/Canada Toll-Free No. +44 2032 894158

Email: [email protected]
Web: https://www.fnfresearch.com

Logo – https://mma.prnewswire.com/media/1981423/FnF_Research_Logo.jpg

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/usd-700-billion-growth-in-nutraceuticals-market-size-2023—industry-analysis-market-trends-market-growth-opportunities–sector-growing-at-9-4-cagr-during-the-forecast-period-2023-to-2030–301873048.html

Advertisement
Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

DC to VC – NatWest Cushon and Future Planet Capital Lead the Charge in UK Pension Access to British Innovation

Published

on

dc-to-vc-–-natwest-cushon-and-future-planet-capital-lead-the-charge-in-uk-pension-access-to-british-innovation

LONDON, Nov. 14, 2024 /PRNewswire/ — Future Planet Capital (FPC) is delighted to be working with NatWest Cushon, with a view to the Cushon Master Trust potentially making an investment in the British Co-Investment Fund (BCF). Any future investment will be subject to commercial terms, due diligence, and Trustee approval. If approved, NatWest Cushon’s participation would signify a major step forward, creating new avenues for British pension funds to access high-growth, private technology companies at scale. In partnership with pension solutions provider Mobius Life, the Fund will channel pension investment into the UK’s most innovative and impactful businesses.  

The BCF closely aligns with the Chancellor of the Exchequer’s vision under the Mansion House Reforms, aiming to unlock large-scale investment in key British industries. It emphasises the private sector’s pivotal role in accelerating innovation and economic growth, through supporting the UK’s most promising and high-impact technology businesses.

Historically, British pension funds have had limited access to high-growth investment opportunities within the UK, meaning that overseas investors have been the primary beneficiaries of the nation’s flourishing innovation economy. Indeed, according to the BVCA, 86% of venture capital investment comes from overseas investors.  To redress the balance, the BCF will be one of the first funds designed specifically for UK regular savings pension funds. It will offer direct and ongoing access to investments in the strategic technologies of the future.

Examples of companies likely to benefit from the Fund’s investments include Tokamak Energy, a world-record holder in nuclear fusion technology. The government-backed UK Innovation and Science Seed Fund (UKI2S), managed by Future Planet Capital, was the first investor in Tokamak Energy, which has since gone on to raise over $250m. This demonstrates the role of public-private partnership in supporting British technology to drive both economic growth and environmental impact. With the support of mainstream British capital, much more can now be done.

Lord Norman Foster, Chair of Future Planet Capital’s Advisory Board shared, “One of our most important tasks is to anticipate the future and find ways to have a positive impact on the wellbeing of people and the planet. We will need intellectual and financial capital to make that happen. This partnership supports the excellent work that is being done to invest in ground-breaking technologies which offer incredible potential.” 

Douglas Hansen-Luke, Executive Chairman and Co-founder of Future Planet Capital, commented, “This collaboration enables British pension savers to support the next generation of British innovation, ensuring that UK capital not only backs but also benefits from the country’s technological and sustainable advancements.”

Julius Pursaill, Pensions expert and advisor to the Cushon Master Trust, said:
“There are a number of good reasons to support the UK Growth agenda. Innovations like the British Co-Investment Fund play an important role in delivering on this objective by driving financial growth whilst also offering access to innovative, impact-focused sectors such as climate technology and artificial intelligence, which can help secure the future for pension savers and broader society.”

About Future Planet Capital

Future Planet Capital is an impact-led venture capital firm built to back growth companies from the world’s top universities and research ecosystems. Founded in Britain with global outlook and reach, Future Planet Capital manages over $460m for public and private investors and has deployed a further $200m of co-investment. With 140 portfolio companies across geographies and stages their mission is to invest in high-growth companies solving global challenges. Mapped against the UN Sustainable Development Goals, these include climate change, education, health, security, and sustainable growth.

For more information visit: https://futureplanetcapital.com/

Advertisement

Other potential investments include: 

Tropic Biosciences, founded in 2016 with an initial investment from Future Planet Capital’s UKI2S fund, is reshaping agriculture to improve resilience, efficiency, and sustainability in food production.

Roslin Technologies, spun out of the University of Edinburgh, pioneers the development of pluripotent stem cells for cultivated meat. Their technology addresses the global protein gap by enabling scalable, sustainable meat production without raising animals. By providing genetically stable, self-replicating stem cells, Roslin delivers solutions that reduce production costs to less than $15/kg, positioning itself as a leader in a $2BN cell market by 2035.

Beam (formally known as Rovco) is a growth-stage autonomous robotics company specialising in subsea services for the offshore wind sector. With £19 million in 2023 revenue, the company is rapidly scaling, leveraging cutting-edge AI and computer vision to lead the way in subsea autonomy.

Quotes of Support:

Lord Wei of Shoreditch
”Changing the world and making an impact at scale is really tough and at times can be a lonely place. Future Planet Capital has managed to pull together globally an immense network of investors, founders, and experts to tackle the biggest challenges facing the world today. It is truly a fellowship, and a font of innovation, as well as being a premier fund platform. In these fast changing times it is so reassuring to know that there are innovators working on making the world a safer, cooler, and better place, whose chances of success are being supercharged through the FPC community.”

Jim Wilkinson, Chief Financial Officer, Oxford Science Enterprises
‘Future Planet Capital’s investment strategy offers not only something different, but something that has been lacking in this space. Its approach as well as its scope -involving a remarkable series of partnerships with leading universities and university venture funds – make it a very valuable strategic partner for anyone active in this field.’

Paul Abberley, Investment Governance Board Chair
CEO at Charles Stanley, one of the oldest firms on the London Stock Exchange. Previously the CEO / CIO of Aviva Investors. 

‘Successful innovations deliver superior investment returns. When those innovations have a positive impact on broader society, the capital investments which makes them possible benefit all stakeholders. Responsible investing of this type is easy to envisage but harder to implement, because identification of suitable opportunities is so challenging. The Future Planet approach bridges that gap.’

Priya Guha OBE, Member of the Future Planet Capital Investment Governance Board
‘With the Chancellor firing the starting gun on this Government’s pension reforms in yesterday’s Mansion House Speech, I am delighted Future Planet Capital are able to announce they are in discussion with NatWest Cushon for an investment into the British Co-Investment Fund.  With their strong reputation for investing in high-growth high-impact companies in the technology sector, Future Planet Capital’s BCF is exactly the right vehicle through which pension funds can back the scaling companies of the future; a win-win for British scale-ups and for British pensioners.’

Advertisement

Matthew Hurn OBE, Deputy Chair of Future Planet Capital’s Advisory Board
‘The UK Growth agenda presents an exciting opportunity and it is vital that we have in place the tools needed to fulfil this potential. I strongly welcome this partnership which signals an important step forward – helping to pave the way to greater financial growth while offering savers access to world leading, impactful innovation.’

View original content:https://www.prnewswire.co.uk/news-releases/dc-to-vc–natwest-cushon-and-future-planet-capital-lead-the-charge-in-uk-pension-access-to-british-innovation-302306339.html

Continue Reading

Fintech PR

Universal Consulting Opportunities (UCO), a Stellar MLS Subsidiary, Signs Agreement with NAR India As Advisor to Develop a National MLS

Published

on

universal-consulting-opportunities-(uco),-a-stellar-mls-subsidiary,-signs-agreement-with-nar-india-as-advisor-to-develop-a-national-mls

ALTAMONTE SPRINGS, Fla., Nov. 14, 2024 /PRNewswire/ — UCO, a subsidiary of Stellar MLS, a leading multiple listing service (MLS) in the U.S. and the fastest-growing in the world, has entered into a landmark agreement with the National Association of REALTORS® (NAR) India as an advisor to successfully launch an MLS across India. This milestone signifies Stellar MLS’s commitment to enhance the real estate industry on a global scale, expanding UCO’s presence worldwide, and furthers NAR India’s journey to modernize and elevate the Indian real estate industry.

Founded in 2008, NAR India is a nonprofit organization that facilitates the professional development of its members and promotes the highest standards and accreditation in the national real estate industry. It is one of only two countries to hold the NAR designation; Canada is the other. UCO will consult with NAR India’s team to guide in areas including the establishment of an MLS, technology, business strategy, organizational setup, and vendor management.

“We are delighted to align with NAR India, a highly respected organization that shares our values of quality customer service, trust and data integrity to benefit the burgeoning real estate market in India,” said Merri Jo Cowen, CEO of UCO and Stellar MLS. “This is a significant nationwide initiative, and we are proud to share our expertise in establishing the MLS concept across India and be a part of NAR India’s mission to utilize the power of collaboration, transparency and an efficient marketplace.”

Cowen also noted the alignment’s potential benefits to Stellar MLS’s Florida customers, such as through referral opportunities: Florida is home to many Non-Resident Indians (NRIs). Current trends highlight the increasing influence of NRIs in shaping India’s real estate landscape, driven by both emotional connections to their homeland and the pursuit of investment opportunities. On the flipside, India is one of the largest foreign investors in Florida real estate, with $5.4 billion in investments in 2020.

“The partnership between UCO and NAR India marks a pivotal moment for the Indian real estate industry,” said Amit Chopra, President, NAR India. “It brings cutting-edge MLS expertise to India, fostering transparency, trust, and professionalism in our market.”

Tarun Bhatia, Vice Chairman and Chair-Global, NAR India, added: “It also creates exciting opportunities for Indian REALTORS® to showcase properties to a global audience, particularly NRIs, fostering stronger international connections.”

Sumanth Reddy, Chairman, NAR India, concluded: “We are proud to embark on this journey with UCO and look forward to the transformative impact it will have on our members and the industry as a whole, opening up new avenues for growth and collaboration.”

Dr. Mathew Kallumadil, UCO Vice President of Global Markets and Stellar MLS Vice President of Technology and Innovation noted the shared synergies between UCO and NAR India. “India is a complex, diverse market with different languages and cultures within the country, and UCO’s experience in accommodating regional differences and helping build scalable MLS systems will be invaluable in developing a sustainable MLS framework,” Dr. Kallumadil said. “Indian society is very highly digitized, and that is critical to a successful MLS and the ecosystem around it.”

The partnership with NAR India expands UCO’s presence to South Asia, in addition to Europe and the Middle East. UCO recently entered into other strategic global consulting opportunities, including with MLS Leader (Romania) and Arab MLS (Middle East) to optimize real estate practices across their respective regions, and with Igluu, a Prague-based digital technology firm, to expand the MLS concept in Europe. Furthermore, UCO has been actively engaged in global forums to support a forward-thinking approach to transforming the industry and its presence is supported through its partnerships with CEPI, the European Association of Real Estate Professions, and FIABCI, the International Real Estate Federation.

For information about UCO and Stellar MLS, visit stellarmls.com/global.

Advertisement

Media Contact: Caryn McBride
Co-Communications
[email protected]

Photo – https://mma.prnewswire.com/media/2558237/Stellar_MLS_NAR_India.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/universal-consulting-opportunities-uco-a-stellar-mls-subsidiary-signs-agreement-with-nar-india-as-advisor-to-develop-a-national-mls-302306185.html

Continue Reading

Fintech PR

Noble Corporation plc announces submission of request for removal from trading and official listing on Nasdaq Copenhagen

Published

on

noble-corporation-plc-announces-submission-of-request-for-removal-from-trading-and-official-listing-on-nasdaq-copenhagen

SUGAR LAND, Texas, Nov. 14, 2024 /PRNewswire/ — Noble Corporation plc (“Noble“, the “Company“) (NYSE: NE, CSE: NOBLE) announces that today, Noble has submitted a request for the voluntary removal of its shares (in the form of share entitlements) (the “Danish Shares“) from trading and official listing on Nasdaq Copenhagen A/S (“Nasdaq Copenhagen“) (the “Delisting“) pursuant to Rule 22(ii) of Supplement A of the Nordic Main Market Rulebook for Issuers of Shares. If Nasdaq Copenhagen accepts the request for voluntary delisting, Noble expects the Delisting to occur by mid-December 2024.

The request for the Delisting will not affect Noble’s listing on the New York Stock Exchange and Noble will remain traded on the New York Stock Exchange as Noble’s primary listing exchange.

Background for applying for the Delisting

As described in Noble’s company announcement of July 18, 2024, following a comprehensive review, Noble believes that the trading volume of its Danish Shares on Nasdaq Copenhagen no longer justifies the expense and administrative requirements associated with maintaining this dual listing. Noble’s primary listing on the New York Stock Exchange provides its shareholders with sufficient liquidity, as the New York Stock Exchange accounts for approximately 99% of its trading volume. The substantial savings in exchange fees, legal fees, and managerial time and effort to maintain a dual listing can be redirected to initiatives intended to generate shareholder value.

Consequently, the board of directors of Noble has resolved to request Nasdaq Copenhagen for a Delisting of Noble.

Possible courses of action for holders of Noble’s Danish Shares

Provided that Noble’s request for Delisting is accommodated, holders of Danish Shares may:

  • Dispose of their Danish Shares on Nasdaq Copenhagen before the Delisting is effective; or
  • Convert their Danish Shares to an equivalent number of Noble shares tradeable on the New York Stock Exchange (“Noble NYSE Shares“).

Alternatively, holders of Danish Shares may do nothing but will hold an illiquid asset following the Delisting.

Disposal of Danish Shares before the Delisting is effective

Following receipt of the expected approval of Noble’s Delisting, the Danish Shares will remain tradeable on Nasdaq Copenhagen for a period of approximately 4 weeks. As such, it will be possible to dispose of the Danish Shares on Nasdaq Copenhagen within the trading period.

Conversion of Danish Shares to Noble NYSE Shares

Advertisement

If holders of Danish Shares want to continue to own publicly tradeable Noble shares after the Delisting, the shareholder must convert its Danish Shares into Noble NYSE Shares either before or after the Delisting.

To convert Danish Shares to Noble NYSE Shares, the holder of Danish Shares must instruct its financial intermediary (bank or broker) to contact Euronext Securities Copenhagen (Noble’s Danish transfer agent). The procedure for converting Danish Shares into Noble NYSE Shares may take several trading days.

To receive Noble NYSE Shares, the shareholder must be able to take delivery of shares issued through The Depository Trust Company (“DTC“). This requires access to a U.S. securities account.

Furthermore, holders of Danish Shares should contact their financial intermediary (bank or broker) about handling fees for the conversion of Danish Shares into Noble NYSE Shares and costs associated with holding shares in DTC and trading on the New York Stock Exchange. Any such costs may be borne by the individual shareholder. Noble currently pays ‘safe keeping’ fees for holders who hold Danish Shares and will continue to do so only until the anticipated Delisting, at which time any holders of Danish Shares who have not converted their Danish Shares into Noble NYSE Shares or disposed of their Danish Shares shall be responsible for these fees on their unlisted Danish Shares.

Holders of Danish Shares should contact their financial intermediary (bank or broker) to assist with any conversion and to answer any questions on process or fees.

Retaining Danish Shares as unlisted securities

Following the Delisting, any Danish Shares not sold or converted will cease to be admitted to trading and official listing on Nasdaq Copenhagen (or any stock exchange). As such, shareholders holding Danish Shares will have an illiquid asset and will most likely need to convert their Danish Shares into Noble NYSE Shares (see above) if and when they wish to sell their shares. A shareholder holding Danish Shares will continue to be able to convert their Danish Shares into Noble NYSE Shares after the Delisting, subject to certain fees.

Certain financial intermediaries (banks or brokers) may have policies regarding shares that are delisted and may require conversion from Danish Shares into Noble NYSE Shares. Please contact your financial intermediary, bank, broker or financial adviser for assistance.

Changes for shareholders holding Danish Shares

Shareholder rights

Advertisement

The ordinary shareholder rights associated with holding Danish Shares will remain unchanged following the Delisting. Consequently, if shareholders holding Danish Shares choose to retain their Danish Shares after the Delisting is effective, they will retain the same shareholder rights as prior to the Delisting, i.e., the right to vote at general meetings and receive dividends, etc. The Danish Shares will continue to be registered in Euronext Securities Copenhagen.

In addition, the shareholder rights, including entitlements to dividends and voting rights, associated with holding Noble NYSE Shares are the same as those associated with the holding Danish Shares. However, whereas the Danish Shares are eligible to receive dividends in DKK and while still admitted to trading and official listing on Nasdaq Copenhagen are traded in DKK, the Noble NYSE Shares are traded in USD and are eligible to receive dividends in USD.

Disclosure requirements

Shareholders holding Danish Shares should be advised that subsequent to the Delisting becoming effective, the shares of Noble will not be subject to the disclosure requirements applicable for companies with shares admitted to trading and official listing on Nasdaq Copenhagen. However, Noble will through its the primary listing of its shares on the New York Stock Exchange remain subject to the extensive disclosure requirements under U.S. securities laws and the rules and regulations of the New York Stock Exchange.

Tax consequences 

The shareholders holding Danish Shares are treated as owning listed shares for Danish tax purposes.

The Delisting should not have any adverse Danish tax impact on Danish tax residents who choose to convert their Danish Shares and thus after the Delisting will hold Noble NYSE Shares.

The shareholders holding Danish Shares who choose to dispose of their Danish Shares will be taxed as a sale of listed shares.

The above assessments should apply to all Danish shareholders holding Danish Shares, regardless of whether they are individuals or corporate entities. Non-Danish shareholders are generally not taxable on a sale of Danish listed shares.

The shareholders holding Danish Shares that do not sell or convert their Danish Shares, and thus retain their Danish Shares after the Delisting, are expected to continue to own listed shares for Danish tax purposes. A binding ruling has been sought to confirm this expectation, but at the time of this announcement, no final ruling has yet been issued by the Danish tax authorities. If the Danish Shares are deemed to be unlisted for Danish tax purposes after the Delisting, the Delisting itself may trigger taxation for certain Danish tax resident individuals.   

Advertisement

Noble does not provide tax or legal advice and the above information is informational only. Please note that as each holder of Danish Shares’ circumstances may differ, Noble encourages each holder of Danish Shares to consult with their own tax and/or financial adviser.

About Noble Corporation
Noble is a leading offshore drilling contractor for the oil and gas industry. The Company owns and operates one of the most modern, versatile, and technically advanced fleets in the offshore drilling industry. Noble and its predecessors have been engaged in the contract drilling of oil and gas wells since 1921. Noble performs, through its subsidiaries, contract drilling services with a fleet of offshore drilling units focused largely on ultra-deepwater and high specification jackup drilling opportunities in both established and emerging regions worldwide. For further information visit www.noblecorp.com or email [email protected].

IMPORTANT INFORMATION
This announcement is for information purposes only and does not constitute or contain any invitation, solicitation, recommendation, offer or advice to any person to subscribe for or otherwise acquire or dispose of any securities of Noble.

Certain statements in this announcement, including any attachments hereto, may constitute forward-looking statements. Forward-looking statements are statements (other than statements of historical fact) relating to future events and Noble and its subsidiaries (collectively, the “Noble Group“). The words “targets”, “believes”, “continues”, “expects”, “aims”, “intends”, “plans”, “seeks”, “will”, “may”, “might”, “anticipates”, “would”, “could”, “should”, “estimates”, “projects”, “potentially” or similar expressions or the negatives thereof, identify certain of these forward-looking statements. The absence of these words, however, does not mean that the statements are not forward-looking. Other forward-looking statements can be identified in the context in which the statements are made.

Although Noble believes that the expectations reflected in these forward-looking statements are reasonable as of the date of this announcement, such forward-looking statements are based on Noble’s current expectations, estimates, forecasts, assumptions and projections about the particular events in question.

Any forward-looking statements included in this announcement, including any attachment hereto, speak only as of today. Noble does not intend, and does not assume, any obligations to update any forward-looking statements contained herein, except as may be required by law or the rules of the New York Stock Exchange or Nasdaq Copenhagen. All subsequent written and oral forward-looking statements attributable to Noble or to persons acting on its behalf are expressly qualified in their entirety by the cautionary statements referred to above and contained in this announcement, including any attachment hereto.

View original content:https://www.prnewswire.co.uk/news-releases/noble-corporation-plc-announces-submission-of-request-for-removal-from-trading-and-official-listing-on-nasdaq-copenhagen-302306031.html

Continue Reading
Advertisement
Advertisement European Gaming Congress 2024

Latest news

Trending